Medicine and Dentistry
Adverse Event
33%
Case Management
33%
Clinical Trial
100%
Clinician
100%
Co-creation
33%
Drug Megadose
100%
Health System
33%
Internal Medicine
100%
Low Drug Dose
33%
Medical Student
50%
Medicine
50%
Patient Care
66%
Patient Referral
33%
Patient Safety
33%
Plasmodium Vivax Malaria
100%
Primaquine
33%
Single Drug Dose
33%
Tafenoquine
33%
Tropical Disease
50%
Visceral Leishmaniasis
50%
Nursing and Health Professions
Adverse Event
33%
Case Management
33%
Drug Megadose
100%
Health Care Facility
33%
Health Care Personnel
66%
Low Drug Dose
33%
Patient Care
66%
Patient Preference
100%
Patient Referral
33%
Patient Safety
33%
Plasmodium Vivax Malaria
100%
Primaquine
33%
Single Drug Dose
33%
Study Participant
100%
Symptom Assessment
33%
Tafenoquine
33%
Pharmacology, Toxicology and Pharmaceutical Science
Adverse Event
33%
Plasmodium Vivax Malaria
100%
Primaquine
33%
Randomized Controlled Trial
100%
Tafenoquine
33%
